Islet transplantation can reduce the dependence of patients with exogenous insulin, and effectively control blood sugar levels and reduce the occurrence of complications by increasing the number of islet cells with endocrine function to treat or even cure diabetes (Shapiro et al., 2000; Bellin et al., 2012; Hering et al., 2016). This evidence concerns the gene INS and diabetes mellitus.